Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04853641 · ClinicalTrials.gov registry record
Impact of Age and BMI on Liver Transplant Outcomes
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 700
- Enrollment target
NCT04853641: Completed study, sponsored by University of Pittsburgh.
NCT04853641 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 700 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04853641 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 700 participants
- Enrollment target
Study Summary
Prospectively enrolled retrospective chart review and Liver Transplant database review to determine the modifiable and nonmodifiable risk factors specifically relating to Living Donor Liver Transplants. To observe the impact of age and BMI on graft outcomes and whether they impact the intraoperative management, post-operative length of stay, and complications.
Primary Outcome
How well does the organ function
Interventions
- PROCEDURE Cadaveric
- PROCEDURE Living Donor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2022-11-30 |
What the finished NCT04853641 record still lists
NCT04853641 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Cadaveric is the first listed.
NCT04853641 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04853641 about?
NCT04853641 is a clinical study titled "Impact of Age and BMI on Liver Transplant Outcomes". Prospectively enrolled retrospective chart review and Liver Transplant database review to determine the modifiable and nonmodifiable risk factors specifically relating to Living Donor Liver Transplants. To observe the impact of age and BMI on graft outcomes and whether they impact the intraoperative...
What is the current status of trial NCT04853641?
This trial is currently completed. The enrollment target is 700 participants. The study started on 2020-07-01. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT04853641?
The interventions under investigation include: Cadaveric (PROCEDURE), Living Donor (PROCEDURE).
Who is sponsoring clinical trial NCT04853641?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI